Eastwood, S.M.; Meyer, M.R.; Kirmess, K.M.; Wente-Roth, T.L.; Irvin, F.; Holubasch, M.S.; Verghese, P.B.; West, T.; Braunstein, J.B.; Yarasheski, K.E.;
et al. PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology. Diagnostics 2024, 14, 1739.
https://doi.org/10.3390/diagnostics14161739
AMA Style
Eastwood SM, Meyer MR, Kirmess KM, Wente-Roth TL, Irvin F, Holubasch MS, Verghese PB, West T, Braunstein JB, Yarasheski KE,
et al. PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology. Diagnostics. 2024; 14(16):1739.
https://doi.org/10.3390/diagnostics14161739
Chicago/Turabian Style
Eastwood, Stephanie M., Matthew R. Meyer, Kristopher M. Kirmess, Traci L. Wente-Roth, Faith Irvin, Mary S. Holubasch, Philip B. Verghese, Tim West, Joel B. Braunstein, Kevin E. Yarasheski,
and et al. 2024. "PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology" Diagnostics 14, no. 16: 1739.
https://doi.org/10.3390/diagnostics14161739
APA Style
Eastwood, S. M., Meyer, M. R., Kirmess, K. M., Wente-Roth, T. L., Irvin, F., Holubasch, M. S., Verghese, P. B., West, T., Braunstein, J. B., Yarasheski, K. E., & Contois, J. H.
(2024). PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology. Diagnostics, 14(16), 1739.
https://doi.org/10.3390/diagnostics14161739
